Gan & Lee Pharmaceuticals Hits Day Low Amid Price Pressure at CNY 55.80

Gan & Lee Pharmaceuticals Co., Ltd. experienced a notable decline today, with the stock dropping by 5.78% on March 23, 2026. The stock reached an intraday low of CNY 55.80, reflecting a challenging trading session. Over the past week, the stock has seen a decrease of 9.24%, and its performance over the last month shows a decline of 13.53%. Despite these short-term fluctuations, Gan & Lee Pharmaceuticals has demonstrated a strong performance over the past year, generating a return of 25.39%, significantly outperforming the China Shanghai Composite, which recorded a return of 13.33%. The company has reported positive results for the last eight consecutive quarters, with net sales growing by 23% in the most recent half-year period. Financial metrics indicate a market capitalization of CNY 34,515 million, with a price-to-earnings ratio of 54.00. The company maintains a high dividend yield of 1.64%, and its return on equity stands at 7.75%. While the stock's recent performance may raise questions, its long-term growth trajectory and market position remain noteworthy within the pharmaceuticals and biotechnology sector.